Section 296-20-385. Categories of persisting variable respiratory impairment with normal baseline spirometry.  


Latest version.
  • (1) "Normal" bronchial reactivity is demonstrated by an insignificant (less than twenty percent) fall from baseline FEV1 at test doses of histamine or methacholine, up to 16 mg/ml (continuous inhalation method) or up to 160 breath units (cumulative, repeated deep breath technique).
    (2) "Mild" bronchial hyperactivity (BHR) is a significant (equal to or greater than twenty percent) fall in the FEV1 at test doses of 2.1-16 mg/ml, or 21-160 breath units.
    (3) "Moderate" BHR is a significant (equal to or greater than twenty percent) fall in the FEV1 at test doses of 0.26-2 mg/ml, or 2.6-20 breath units.
    (4) "Marked" BHR is a significant (equal to or greater than twenty percent) fall in the FEV1 at test doses equal to or less than .25 mg/ml, or 2.5 breath units.
    [Statutory Authority: RCW 51.04.020(4), 51.04.030 and 51.32.080(2). WSR 94-03-073, § 296-20-385, filed 1/17/94, effective 3/1/94.]
RCW 51.04.020(4), 51.04.030 and 51.32.080(2). WSR 94-03-073, § 296-20-385, filed 1/17/94, effective 3/1/94.